Literature DB >> 2229523

Pharmacology of the allylamines.

J E Birnbaum1.   

Abstract

The allylamines are a new class of antifungal drugs that inhibit ergosterol synthesis at the level of squalene epoxidase. These agents are highly selective for the fungal enzyme and have a minimal effect on mammalian cholesterol synthesis. Naftifine, the original member of the allylamine series, possesses only topical activity, whereas the naftifine analog terbinafine is active both topically and orally. In vitro, terbinafine is exceptionally active against dermatophytes, molds, and dimorphic fungi in which it exerts a fungicidal action. This in vitro profile is reflected by the clinical effectiveness of this allylamine in the treatment of dermatophyte infections. When given orally, terbinafine is well absorbed and rapidly and extensively distributed to the skin and sebum in concentrations that exceed the minimum inhibitory concentrations of these organisms by several orders of magnitude.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2229523     DOI: 10.1016/0190-9622(90)70288-s

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  12 in total

Review 1.  Adverse drug reactions to systemic antifungals. Prevention and management.

Authors:  J R Perfect; M H Lindsay; R H Drew
Journal:  Drug Saf       Date:  1992 Sep-Oct       Impact factor: 5.606

Review 2.  The Future of Antifungal Drug Therapy: Novel Compounds and Targets.

Authors:  Caroline Mota Fernandes; Deveney Dasilva; Krupanandan Haranahalli; J Brian McCarthy; John Mallamo; Iwao Ojima; Maurizio Del Poeta
Journal:  Antimicrob Agents Chemother       Date:  2021-01-20       Impact factor: 5.191

3.  Rhabdomyolysis and Acute Kidney Injury Associated With Terbinafine Use: A Case Report.

Authors:  Shijie Zhou; Amit Bagga
Journal:  Can J Kidney Health Dis       Date:  2020-10-22

Review 4.  Treatment and prophylaxis of tinea infections.

Authors:  G E Piérard; J E Arrese; C Piérard-Franchimont
Journal:  Drugs       Date:  1996-08       Impact factor: 9.546

5.  In vitro antifungal activity of naftifine hydrochloride against dermatophytes.

Authors:  M Ghannoum; N Isham; A Verma; S Plaum; A Fleischer; B Hardas
Journal:  Antimicrob Agents Chemother       Date:  2013-07-01       Impact factor: 5.191

6.  [Generation of reactive oxygen species in vitro by Malassezia yeasts].

Authors:  S Später; U-C Hipler; U-F Haustein; P Nenoff
Journal:  Hautarzt       Date:  2009-02       Impact factor: 0.751

Review 7.  The dermatophytes.

Authors:  I Weitzman; R C Summerbell
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

8.  Update on terbinafine with a focus on dermatophytoses.

Authors:  Jason G Newland; Susan M Abdel-Rahman
Journal:  Clin Cosmet Investig Dermatol       Date:  2009-04-21

Review 9.  Emerging Antifungal Targets and Strategies.

Authors:  Marija Ivanov; Ana Ćirić; Dejan Stojković
Journal:  Int J Mol Sci       Date:  2022-03-02       Impact factor: 5.923

10.  Benzylic Dehydroxylation of Echinocandin Antifungal Drugs Restores Efficacy against Resistance Conferred by Mutated Glucan Synthase.

Authors:  Dana Logviniuk; Qais Z Jaber; Roman Dobrovetsky; Noga Kozer; Ewa Ksiezopolska; Toni Gabaldón; Shmuel Carmeli; Micha Fridman
Journal:  J Am Chem Soc       Date:  2022-03-29       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.